Effect of vanadate on renal tubular function in rats.
Orthovanadate (VO4) has been shown to cause a marked natriuresis in rats. This has been ascribed to its inhibitory action on renal Na-K-ATPase activity. Because virtually all nephron segments possess Na-K-ATPase activity the administration of VO4 should alter renal tubular transport along the entire nephron. To examine this possibility, adult rats were anesthetized and infused with VO4 (10 mumol.kg body wt-1.h-1 i.v.). This dose had no effect on glomerular filtration rate, effective renal plasma flow, and blood pressure, whereas urine flow and sodium and water excretion rose markedly. Potassium excretion remained unaltered. VO4 depressed only maximal bicarbonate and glucose reabsorption without causing a glucose or bicarbonate "leak" at normal levels of blood glucose or bicarbonate. In acutely thyroparathyroidectomized rats VO4 produced a striking phosphaturia, not accompanied by an increase in nephrogenous cAMP excretion. Both free water clearance in Brattleboro rats and free water reabsorption in normal rats was significantly depressed by VO4. These data demonstrate that VO4 depresses tubular reabsorption in proximal and distal nephron segments. We conclude that VO4 exerts its effect on tubular function by inhibition of Na-K-ATPase activity.
D000818:Animals; D001639:Bicarbonates / Q000378:metabolism; D001794:Blood Pressure / Q000187:drug effects; D001834:Body Water / Q000378:metabolism; D000242:Cyclic AMP / Q000378:metabolism; D003919:Diabetes Insipidus / Q000503:physiopathology; D005919:Glomerular Filtration Rate / Q000187:drug effects; D005947:Glucose / Q000378:metabolism; D007684:Kidney Tubules / Q000187:drug effects / Q000502:physiology*; D008297:Male; D010710:Phosphates / Q000378:metabolism; D051381:Rats; D014556:Urine / Q000187:drug effects; D014638:Vanadates; D014639:Vanadium / Q000494:pharmacology*
D001639:Bicarbonates; D010710:Phosphates; D014639:Vanadium; D014638:Vanadates; D000242:Cyclic AMP; D005947:Glucose